Yue has a PhD of Pharmacology from Cambridge University, with a professional career spanning healthcare and consulting, focused on the intersection of data, technology and clinical transformation.

In 2022, Yue experienced the full-term stillbirth of her daughter, an experience that has shaped her commitment to improving maternity and bereavement care.

She has expertise in translating scientific evidence into real-world practice. She successfully supported the release of UK government funding for a maternity clinical decision support tool, helping to embed research-led risk stratification into routine care.

Yue brings to the Board a combination of lived experience, scientific training and strategic delivery expertise.